The California Department of Justice (DOJ) is making important changes to the Controlled Substance Utilization Review and Evaluation System, known as CURES. CURES is the database that collects all Schedule II-V controlled substance prescriptions issued in California. Prescribers must consult CURES when a patient is first prescribed, prescribed, or administered a Schedule II-IV controlled substance.
The CURES update will provide an improved user interface and new system features, including features approved by recent legislation. In preparation for the delivery of these changes, CURES will be unavailable from April 8 at 5:00 p.m. to April 11 at 8:00 a.m
The CURES update will also provide enhanced functionality that authorizes delegates to access data in CURES. In order for existing delegates to continue their CURES access after April 11, 2022 and for new delegates to be added after April 11, 2022, the delegate’s authorized CURES users must:
- Confirm the delegate’s permission
- Enter into a “delegate agreement”.
- Register the delegate in CURES after April 11, 2022
The criteria for the eligibility of the delegate and the necessary contents of a delegate agreement can be found in the DOJ memo “New features and requirements for Enhanced Delegate Access.”
Practices should also be aware that as of April 11, 2022, the Internet Explorer web browser will no longer be allowed to access the CURES web application due to application and data security concerns. CURES users should switch to one of the following web browsers: Google Chrome, Microsoft Edge, Safari or Mozilla Firefox.
Practices with questions may contact the CURES program at [email protected] or (916) 210-3187.
For more informations: